Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Immunome, Inc. (IMNM)

17.56 -1.59 (-8.33%)
As of 1:52:04 PM EDT. Market Open.
Trade IMNM on Coinbase
Chart Range Bar
Loading chart for IMNM
  • Previous Close 19.15
  • Open 19.06
  • Bid 13.72 x 200
  • Ask 23.21 x 200
  • Day's Range 17.43 - 19.16
  • 52 Week Range 13.53 - 30.06
  • Volume 939,270
  • Avg. Volume 1,200,278
  • Market Cap (intraday) 2.072B
  • Beta (5Y Monthly) 2.56
  • PE Ratio (TTM) --
  • EPS (TTM) -2.52
  • Earnings Date (est.) Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 35.20

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

immunome.com

247

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 10/13/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IMNM
18.27%
S&P 500 (^GSPC)
13.88%

1-Year Return

IMNM
23.19%
S&P 500 (^GSPC)
17.14%

3-Year Return

IMNM
95.27%
S&P 500 (^GSPC)
80.13%

5-Year Return

IMNM
0.31%
S&P 500 (^GSPC)
78.64%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue --
Earnings -73.13M
Profit Margin 0.00%

Q2

FY25

Q3

FY25

Q4

FY25

Q2

FY26

-60M
-40M
-20M
0
-1000.0%
-800.0%
-600.0%
-400.0%
-200.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

24.00
35.20 Average
17.56 Current
40.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/1/2026
Analyst Stifel
Rating Action Initiated
Rating Hold
Price Action Announces
Price Target 24

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    2.75B

  • Enterprise Value

    2.24B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    612.75

  • Price/Book (mrq)

    5.24

  • Enterprise Value/Revenue

    580.28

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -37.78%

  • Return on Equity (ttm)

    -64.03%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -254.32M

  • Diluted EPS (ttm)

    -2.52

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    520M

  • Total Debt/Equity (mrq)

    0.90%

  • Levered Free Cash Flow (ttm)

    -143.66M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

17.56 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 06/10/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 04/01/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Insider Picks for 03/18/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/17/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: